Basic Research
Copyright ©The Author(s) 2005.
World J Gastroenterol. Oct 7, 2005; 11(37): 5795-5800
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5795
Figure 1
Figure 1 Change of MDA content in liver homogenates of mice with hepatic injury after Se-enriched lactobacillus treatment. aP < 0.05 vs model group; cP < 0.05 vs normal group.
Figure 2
Figure 2 Change of plasma TNF-α level in mice with hepatic injury after Se-enriched lactobacillus treatment. aP < 0.05 vsmodel group; cP < 0.05 vs normal group.
Figure 3
Figure 3 [Ca2+]i fluorescence visualizations (A) and intensities (B) in mice with hepatic injury after Se-enriched lactobacillus treatment. aP < 0.05 vs model group; cP < 0.05 vs normal group.